Penault-Llorca F - Search Results

1

Is there an immunohistochemical technique definitively valid in epidermal growth factor receptor assessment?

Penault-Llorca F, Cayre A, Arnould L, Bibeau F, Bralet MP, Rochaix P, Savary J, Sabourin JC. Penault-Llorca F, et al. Oncol Rep. 2006 Dec;16(6):1173-9. Oncol Rep. 2006. PMID: 17089034

2

Pgp immunochemistry: use with caution: correspondence re: C-H. Kao et al., P-glycoprotein and multidrug resistance-related protein expressions in relation to technetium-99m methoxyisobutylisonitrile scintimammography findings. Cancer Res., 61: 1412-1414, 2001.

Cayre A, Maublant J, Penault-Llorca F. Cayre A, et al. Cancer Res. 2002 Jan 15;62(2):617. Cancer Res. 2002. PMID: 11809718 No abstract available.

3

Single static view 99mTc-sestamibi scintimammography predicts response to neoadjuvant chemotherapy and is related to MDR expression.

Cayre A, Cachin F, Maublant J, Mestas D, Feillel V, Ferrière JP, Kwiaktowski F, Chevillard S, Finat-Duclos F, Verrelle P, Penault-Llorca F. Cayre A, et al. Int J Oncol. 2002 May;20(5):1049-55. Int J Oncol. 2002. PMID: 11956603

4

[Immunochemistry evaluation of HER2 status in infiltration breast cancer: technical protocol and interpretation guidelines].

Penault-Llorca F, Balaton A, Sabourin JC, Le Doussal V; Groupe d'évaluation des facteurs pronostiques par immunohistochimie dans les cancers du sein (GEFPICS). Penault-Llorca F, et al. Ann Pathol. 2002 Apr;22(2):150-7. Ann Pathol. 2002. PMID: 12124503 French.

5

O(6)-methylguanine-DNA methyl transferase gene expression and prognosis in breast carcinoma.

Cayre A, Penault-Llorca F, De Latour M, Rolhion C, Feillel V, Ferrière JP, Kwiatkowski F, Finat-Duclos F, Verrelle P. Cayre A, et al. Int J Oncol. 2002 Nov;21(5):1125-31. Int J Oncol. 2002. PMID: 12370764

6

Calibration of immunohistochemistry for assessment of HER2 in breast cancer: results of the French multicentre GEFPICS study.

Vincent-Salomon A, MacGrogan G, Couturier J, Arnould L, Denoux Y, Fiche M, Jacquemier J, Mathieu MC, Penault-Llorca F, Rigaud C, Roger P, Treilleux I, Vilain MO, Mathoulin-Pélissier S, Le Doussal V. Vincent-Salomon A, et al. Histopathology. 2003 Apr;42(4):337-47. doi: 10.1046/j.1365-2559.2003.01598.x. Histopathology. 2003. PMID: 12653945

7

Induction chemotherapy for breast carcinoma: predictive markers and relation with outcome.

Penault-Llorca F, Cayre A, Bouchet Mishellany F, Amat S, Feillel V, Le Bouedec G, Ferrière JP, De Latour M, Chollet P. Penault-Llorca F, et al. Int J Oncol. 2003 Jun;22(6):1319-25. Int J Oncol. 2003. PMID: 12739000

8

Agreement between chromogenic in situ hybridisation (CISH) and FISH in the determination of HER2 status in breast cancer.

Arnould L, Denoux Y, MacGrogan G, Penault-Llorca F, Fiche M, Treilleux I, Mathieu MC, Vincent-Salomon A, Vilain MO, Couturier J. Arnould L, et al. Br J Cancer. 2003 May 19;88(10):1587-91. doi: 10.1038/sj.bjc.6600943. Br J Cancer. 2003. PMID: 12771927 Free PMC article.

9

aHIF but not HIF-1alpha transcript is a poor prognostic marker in human breast cancer.

Cayre A, Rossignol F, Clottes E, Penault-Llorca F. Cayre A, et al. Breast Cancer Res. 2003;5(6):R223-30. doi: 10.1186/bcr652. Epub 2003 Sep 26. Breast Cancer Res. 2003. PMID: 14580258 Free PMC article.

10

[Epidermal growth factor receptors: status evaluation methods and tumor expression].

Penault-Llorca F. Penault-Llorca F. Bull Cancer. 2003 Nov;90 Spec No:S186-91. Bull Cancer. 2003. PMID: 14763138 Free article. Review. French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

504 results

Search Page

Filters